Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Hayman

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Leukemia|September 28, 2025
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysisSaurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, et al.
Leukemia|December 16, 2024
Capillary leak phenotype as a major cause of death in patients with POEMS syndromeKenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, et al.
British Journal of Haematology|November 24, 2011
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myelomaMeaghan L Khan, Craig B Reeder, Shaji K Kumar, et al.
Leukemia|April 9, 2024
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failuresSaurabh Zanwar, Morie A Gertz, Eli Muchtar, et al.
Blood Cancer Journal|July 23, 2024
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myelomaMatthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, et al.
American Journal of Hematology|December 17, 2019
Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivityMarcella Tschautscher, Dragan Jevremovic, Francis K Buadi, et al.
Cancer Medicine|October 6, 2020
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatmentIuliana Vaxman, Abdullah S Al Saleh, Shaji Kumar, et al.
Blood Advances|July 9, 2021
Prognostic impact of posttransplant FDG PET/CT scan in multiple myelomaMarcella Kaddoura, David Dingli, Francis K Buadi, et al.
American Journal of Hematology|November 25, 2021
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patientsPatrick W Mellors, Taxiarchis Kourelis, Ronald S Go, et al.
Blood Cancer Journal|October 3, 2020
Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myelomaMarcella A Tschautscher, Dragan Jevremovic, Francis K Buadi, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Leukemia|September 28, 2025
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysisSaurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, et al.
Leukemia|December 16, 2024
Capillary leak phenotype as a major cause of death in patients with POEMS syndromeKenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, et al.
British Journal of Haematology|November 24, 2011
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myelomaMeaghan L Khan, Craig B Reeder, Shaji K Kumar, et al.
Leukemia|April 9, 2024
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failuresSaurabh Zanwar, Morie A Gertz, Eli Muchtar, et al.
Blood Cancer Journal|July 23, 2024
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myelomaMatthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, et al.
American Journal of Hematology|December 17, 2019
Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivityMarcella Tschautscher, Dragan Jevremovic, Francis K Buadi, et al.
Cancer Medicine|October 6, 2020
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatmentIuliana Vaxman, Abdullah S Al Saleh, Shaji Kumar, et al.
Blood Advances|July 9, 2021
Prognostic impact of posttransplant FDG PET/CT scan in multiple myelomaMarcella Kaddoura, David Dingli, Francis K Buadi, et al.
American Journal of Hematology|November 25, 2021
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patientsPatrick W Mellors, Taxiarchis Kourelis, Ronald S Go, et al.
Blood Cancer Journal|October 3, 2020
Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myelomaMarcella A Tschautscher, Dragan Jevremovic, Francis K Buadi, et al.
Pageof 8